Myanmar, Donors Increase Health Care Spending After Decades of Neglect
This article was originally published in PharmAsia News
Executive Summary
Myanmar is expected to further increase spending on its long-neglected health care system, giving cues to the country’s fledgling pharmaceutical industry. International donors that are re-engaging the country after long years of isolation are also allocating funds to health care.
You may also be interested in...
Regulation, Reimbursement Notes From Thailand
Thailand’s military junta has made few moves to tackle reimbursement reforms since a coup in May. But the appointment of a cabinet this month may signal action on health care spending levels.
Thai Researchers, MMV Launch Preclinical Look For New Anti-Malaria Compound Targeting Mutant Enzymes
Research into anti-malarial drug effectiveness in Thailand prompts a pre-clinical look at novel compound.
Regulation, Reimbursement Notes From Thailand
Thailand struggles to tackle reimbursement reforms as political tension grips the country following a military coup last week. Still the civil service continues to take decisions on budget and spending plans, but domestic and multinational firms are keeping a wary eye on developments.